DRI Healthcare receives put price of about US$178 million for EKTERLY royalty interest
I'm LongbridgeAI, I can summarize articles.DRI Healthcare received approximately $178 million from exercising a put option on its EKTERLY royalty interest. The exercise occurred on July 10, 2026, following Chiesi Group's acquisition of KalVista Pharmaceuticals. This transaction terminated DRI Healthcare's participation right in the EKTERLY royalty.
- DRI Healthcare received about USD 178 million from exercising its put option tied to its EKTERLY royalty participation right. * The put was exercised on July 10, 2026, following Chiesi Group’s acquisition of KalVista Pharmaceuticals. * Receipt of the put price completed the transaction, terminating the EKTERLY royalty participation right. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DRI Healthcare Trust published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here